JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B7085 Cardamonin

Summary: NF-κB inhibitor

insoluble in H2O; insoluble in EtOH; ≥43.5 mg/mL
B7250 YM 750

Summary: Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor

<45.26 mg/mL
B7545 PG 01

Summary: CFTR mutants potentiator

<43.95 mg/mL
B7714 3-Cyano-7-ethoxycoumarin

Summary: Fluorescent P450 substrate

Soluble in DMSO
B7746 PA 452

Summary: RXR antagonist

<43.96 mg/mL
A3022 Pazopanib (GW-786034)

Target: CSF-1R|VEGFR|PDGFR|c-Kit|FGFR

Summary: VEGFR/PDGFR/FGFR inhibitor

insoluble in EtOH; insoluble in H2O; ≥10.95 mg/mL
A4064 NVP-BEP800

Target: HSP90

Summary: Oral Hsp90β inhibitor, novel, fully synthetic
A4070 Elvitegravir (GS-9137)

Target: HIV Integrases

Summary: HIV-1 integrase inhibitor,potent

insoluble in H2O; insoluble in EtOH; ≥20.35 mg/mL
A4159 PJ34 hydrochloride

Summary: PARP inhibitor,potent and cell-permeable

insoluble in H2O; insoluble in EtOH; ≥16.6 mg/mL
A8205 Atazanavir
1 Citation

Summary: HIV protease inhibitor,highly potent

≥28.6 mg/mL